CLDN7 and ovarian carcinoma: In this study claudin-7 was found to be expressed in 69/71 (97.1%) epithelial ovarian cancers but not in normal ovaries (p < 0.001) and high claudin-7 expression in primary tumors correlated with shorter progression-free survival (PFS) of patients and poor sensitivity to platinum based chemotherapy.